Soligenix Applying for Vaccine Development Funding for Bundibugyo Ebola Vaccine

Go back to Soligenix Applying for Vaccine Development Funding for Bundibugyo Ebola Vaccine
Soligenix, Inc. (NASDAQ: SNGX) Delayed: 0.38 -0.01 (2.56%)
Previous Close $0.39    52 Week High $4.35 
Open $0.39    52 Week Low $0.44 
Day High $0.41    P/E N/A 
Day Low $0.38    EPS $-0.81 
Volume 743,461